Growth inhibition, drug load, and degradation studies of gelatin/methotrexate conjugates
Authors:
- Clyde M. OfnerCOClyde M. Ofner
- Karen PicaKPKaren Pica
- Bill J. BowmanBBBill J. Bowman
- 1 February 2006
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 308 (1-2) , 90-99
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Drug Delivery and Transport to Solid TumorsPharmaceutical Research, 2003
- Folate-mediated delivery of macromolecular anticancer therapeutic agentsAdvanced Drug Delivery Reviews, 2002
- Characterization and in vitro release of methotrexate from gelatin/methotrexate conjugates formed using different preparation variablesInternational Journal of Pharmaceutics, 2000
- Cytotoxic and antitumor effect of fibrinogen-methotrexate conjugateCancer Letters, 2000
- Characterization and in vitro methotrexate release from methotrexate/gelatin conjugates of opposite conjugate bond polarity.Pharmaceutical Research, 2000
- Karnofsky memorial lecture. Ode to methotrexate.Journal of Clinical Oncology, 1993
- Quantitation of the synergistic interaction of edatrexate and cisplatin in vitroCancer Chemotherapy and Pharmacology, 1993
- Synthesis of site-specific methotrexate-IgG conjugatesCancer Immunology, Immunotherapy, 1989
- Characterization of in-vitro drug release and biological activity of methotrexate-bovine serum albumin conjugatesJournal of Pharmacy and Pharmacology, 1987
- Biological effects of folic acid antagonists with antineoplastic activityPharmacology & Therapeutics, 1984